Cite
HARVARD Citation
Ino, H. et al. (2019). Evaluation of the Safety, Tolerability, and Pharmacokinetics of GSK2269557 (Nemiralisib) Administered Via Dry Powder Inhaler to Healthy Japanese Subjects. Clinical pharmacology in drug development. 8 (1), pp. 78-86. [Online].